4-Amino-N-(2-(4-(3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropyl)piperidin-1-yl)ethyl)-3,5-dibromobenzenesulfonamide

ID: ALA4799043

Chembl Id: CHEMBL4799043

PubChem CID: 162675700

Max Phase: Preclinical

Molecular Formula: C23H29Br2ClN4O4S

Molecular Weight: 652.84

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCNS(=O)(=O)c2cc(Br)c(N)c(Br)c2)CC1

Standard InChI:  InChI=1S/C23H29Br2ClN4O4S/c1-34-22-13-20(27)19(26)12-16(22)21(31)3-2-14-4-7-30(8-5-14)9-6-29-35(32,33)15-10-17(24)23(28)18(25)11-15/h10-14,29H,2-9,27-28H2,1H3

Standard InChI Key:  ANKWCLUOSBVZSG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4799043

    ---

Associated Targets(Human)

HTR6 Tchem Serotonin 6 (5-HT6) receptor (9749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HTR4 Serotonin 4 (5-HT4) receptor (2870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 652.84Molecular Weight (Monoisotopic): 649.9965AlogP: 4.69#Rotatable Bonds: 10
Polar Surface Area: 127.75Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.60CX Basic pKa: 6.93CX LogP: 3.61CX LogD: 3.48
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.25Np Likeness Score: -1.14

References

1. Yahiaoui S,Hamidouche K,Ballandonne C,Davis A,de Oliveira Santos JS,Freret T,Boulouard M,Rochais C,Dallemagne P.  (2016)  Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.,  121  [PMID:27266998] [10.1016/j.ejmech.2016.05.048]

Source